Tagtociclib (hydrate)
PF-07104091 hydrate is a potent and selective CDK2/cyclin E1 and GSK3β inhibitor, with Kis of 1.16 and 537.81 nM, respectively. PF-07104091 hydrate has anti-tumor activity for cyclin E1-amplified cancers. (patent WO2020157652A2) .
Product Specifications
CAS Number
2733575-91-0
Product Name Alternative
PF-07104091 (hydrate)
UNSPSC
12352005
Target
CDK; GSK-3
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pf-07104091-hydrate.html
Purity
99.73
Solubility
DMSO : 116.67 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(COC)=NN1C)NC2=NNC([C@](CC3)([H])C[C@@H]3OC(NC(C)C)=O)=C2.[H]O[H]
Molecular Formula
C19H30N6O5
Molecular Weight
422.48
References & Citations
[1]Douglas Carl BEHENNA, et al. Cdk2 inhibitors. WO2020157652A2.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
CDK2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PKLR (Pyruvate Kinase, liver and RBC, PK1, PKL, PKR, PKRL, RPK) (PE)
PKLR (Pyruvate Kinase, liver and RBC, PK1, PKL, PKR, PKRL, RPK) (PE)
Anti - Dachshund Homolog 2 (DACH2, Dachshund homolog 2 (Drosophila), RP11-345E19.1, FLJ31391, MGC138545)
Anti - Dachshund Homolog 2 (DACH2, Dachshund homolog 2 (Drosophila), RP11-345E19.1, FLJ31391, MGC138545)
